Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Melanoma 114Carcinoma, Non-Small-Cell Lung 34Neoplasms 26Neoplasm Metastasis 19Prostatic Neoplasms 18Uveal Melanoma 16Carcinoma, Renal Cell 16Lung Neoplasms 14Pancreatic Neoplasms 13Diabetes Mellitus, Insulin-Dependent, 12 12Small Cell Lung Carcinoma 11Colorectal Neoplasms 10Carcinoma, Hepatocellular 9Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Breast Neoplasms 8Sarcoma 7Carcinoma, Transitional Cell 7Brain Neoplasms 7Stomach Neoplasms 6Mesothelioma 6Kidney Neoplasms 6Head and Neck Neoplasms 6Advanced Cancer 6Urinary Bladder Neoplasms 5Recurrence 5Ovarian Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma 5Leukemia, Myeloid, Acute 5

Interventions

pembrolizumab 3Ipilimumab 2Blood Specimen Collection 2spartalizumab 1necitumumab 1mirdametinib 1leronlimab 1apatinib 1Watchful Waiting 1Tomography, X-Ray Computed 1Therapeutics 1Surveys and Questionnaires 1Rosuvastatin Calcium 1Radiotherapy 1Radiation 1Positron-Emission Tomography 1PankoMab-GEX 1Panitumumab 1Nivolumab 1Metformin 1Magnetic Resonance Imaging 1MEK inhibitor I 1Jupiter 1JPT1 protein, human 1Interleukin-2 1Immune Checkpoint Inhibitors 1GAT 1Fluorodeoxyglucose F18 1FCN-437c 1EBI-005 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Solid Tumor, Adult × Ipilimumab × Clear all
NCT03523819 2024-09-19

A Study of CS1002 in Subjects with Advanced Solid Tumors

CStone Pharmaceuticals

Phase 1 Completed
91 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT03728179 2024-02-20

RACIN

Centre Hospitalier Universitaire Vaudois

Phase 1 Completed
40 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡